FDA
approval
· 2022-04-22
FDA Approved: CHATEAL EQ — Supplemental Application (Afaxys Pharma, LLC)
Summary
FDA approved a supplemental application for CHATEAL EQ, a combined oral contraceptive containing levonorgestrel and ethinyl estradiol, submitted by Afaxys Pharm…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CHATEAL EQ (LEVONORGESTREL AND ETHINYL ESTRADIOL)